These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 19820941

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effective anti-TNF-alpha therapy can induce rapid resolution and sustained decrease of gastroduodenal mucosal amyloid deposits in reactive amyloidosis associated with rheumatoid arthritis.
    Kuroda T, Wada Y, Kobayashi D, Murakami S, Sakai T, Hirose S, Tanabe N, Saeki T, Nakano M, Narita I.
    J Rheumatol; 2009 Nov; 36(11):2409-15. PubMed ID: 19797512
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T, Higashi S, Tomoda K, Tsukano M, Shono M.
    Clin Rheumatol; 2010 Dec; 29(12):1395-401. PubMed ID: 20440529
    [Abstract] [Full Text] [Related]

  • 8. Abatacept may be effective and safe in patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T, Kumon Y, Hirata S, Takaoka H.
    Clin Exp Rheumatol; 2014 Dec; 32(4):501-8. PubMed ID: 24959698
    [Abstract] [Full Text] [Related]

  • 9. Anti-TNF therapy in renal amyloidosis in refractory rheumatoid arthritis: a new therapeutic perspective.
    Nobre CA, Callado MR, Rodrigues CE, de Menezes DB, Vieira WP.
    Rev Bras Reumatol; 2010 Dec; 50(2):205-10. PubMed ID: 21125155
    [Abstract] [Full Text] [Related]

  • 10. Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents.
    Wada Y, Kobayashi D, Murakami S, Oda M, Hanawa H, Kuroda T, Nakano M, Narita I.
    Scand J Rheumatol; 2011 Dec; 40(5):402-4. PubMed ID: 21639824
    [No Abstract] [Full Text] [Related]

  • 11. Effect of etanercept on serum amyloid A protein (SAA) levels in patients with AA amyloidosis complicating inflammatory arthritis.
    Perry ME, Stirling A, Hunter JA.
    Clin Rheumatol; 2008 Jul; 27(7):923-5. PubMed ID: 18379834
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Case report: Response in proteinuria due to AA amyloidosis but not Felty's syndrome in a patient with rheumatoid arthritis treated with TNF-alpha blockade.
    Ravindran J, Shenker N, Bhalla AK, Lachmann H, Hawkins P.
    Rheumatology (Oxford); 2004 May; 43(5):669-72. PubMed ID: 15103032
    [No Abstract] [Full Text] [Related]

  • 14. Effectiveness of etanercept vs cyclophosphamide as treatment for patients with amyloid A amyloidosis secondary to rheumatoid arthritis.
    Nakamura T, Higashi S, Tomoda K, Tsukano M, Shono M.
    Rheumatology (Oxford); 2012 Nov; 51(11):2064-9. PubMed ID: 22879465
    [Abstract] [Full Text] [Related]

  • 15. Long-term follow-up of systemic reactive AA amyloidosis secondary to rheumatoid arthritis: successful treatment with intermediate-dose corticosteroid.
    Matsuda M, Morita H, Ikeda S.
    Intern Med; 2002 May; 41(5):403-7. PubMed ID: 12058893
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis.
    Nakamura T, Yamamura Y, Tomoda K, Tsukano M, Shono M, Baba S.
    Clin Rheumatol; 2003 Dec; 22(6):371-5. PubMed ID: 14677008
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Therapy of rheumatoid arthritis with etanercept].
    Lamprecht P, Nitschmann S.
    Internist (Berl); 2009 May; 50(5):633-4. PubMed ID: 19350212
    [No Abstract] [Full Text] [Related]

  • 20. No regression of renal amyloid mass despite remission of nephrotic syndrome in a patient with TRAPS following etanercept therapy.
    Simsek I, Kaya A, Erdem H, Pay S, Yenicesu M, Dinc A.
    J Nephrol; 2010 May; 23(1):119-23. PubMed ID: 20091495
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.